Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parasternal lymphoscintigraphy using 99Tcm-dextran.

B Karayalcin1, G Aras, G Erbay

  • 1Department of Nuclear Medicine, Ankara University Medical School, Turkey.

Nuclear Medicine Communications
|September 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the Effectiveness of Potassium Para-aminobenzoate and Colchicine in the Treatment of Peyronie Disease: A Retrospective Study.

Nigerian journal of clinical practice·2026
Same author

Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy.

The British journal of radiology·2013
Same author

Contractility evaluation by 2 dimensional echocardiography and gated SPECT myocardial perfusion scintigraphy in hypertensive patients with clinical presentation of atypical chest pain.

Hippokratia·2011
Same author

Congenital infiltrating lipomatosis of the face with hemimegalencephaly.

Neuropediatrics·2009
Same author

Tc-Glutathione Complex (Tc -GSH) : Labelling, Chemical Characterization and Biodistribution in Rats.

Metal-based drugs·2008
Same author

Accumulation of 99mTc-Cysteine in experimental inflammatory lesions in comparison to 99mTc-glutamine and 99mTc-HIG.

Nuklearmedizin. Nuclear medicine·2006

Technetium-99m-dextran is a promising radiopharmaceutical for lymphoscintigraphy, offering a simpler, cost-effective alternative to radiocolloids for visualizing lymph node drainage in breast cancer patients.

Area of Science:

  • Nuclear Medicine
  • Radiopharmacology

Background:

  • Lymphoscintigraphy is crucial for staging breast cancer.
  • Current agents like radiocolloids have limitations.

Purpose of the Study:

  • To evaluate 99mTc-dextran as a lymphoscintigraphic agent.
  • To compare its efficacy with radiocolloids.

Main Methods:

  • 10 healthy volunteers and 24 breast cancer patients received 99mTc-dextran injections.
  • Lymphatic drainage patterns were visualized using scintigraphy at various time points.

Main Results:

  • 99mTc-dextran successfully visualized lymph node distribution, including parasternal and supraclavicular nodes.
  • Abnormal patterns were identified in 8 out of 24 breast cancer patients.

Related Experiment Videos

  • Results showed good agreement with literature using radiocolloids.
  • Conclusions:

    • 99mTc-dextran is a viable and promising agent for lymphoscintigraphy.
    • Its ease of labeling, stability, availability, and low cost make it a potential replacement for radiocolloids.